SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-075210
Filing Date
2007-10-17
Accepted
2007-10-17 06:03:18
Documents
13
Period of Report
2007-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-26648_18k.htm 8-K 28994
2 EX-99.1 a07-26648_1ex99d1.htm EX-99.1 16025
3 GRAPHIC g266481mmi001.jpg GRAPHIC 64645
4 GRAPHIC g266481mmi002.jpg GRAPHIC 61521
5 GRAPHIC g266481mmi003.jpg GRAPHIC 68455
6 GRAPHIC g266481mmi004.jpg GRAPHIC 68073
7 GRAPHIC g266481mmi005.jpg GRAPHIC 64979
8 GRAPHIC g266481mmi006.jpg GRAPHIC 57589
9 GRAPHIC g266481mmi007.jpg GRAPHIC 62646
10 GRAPHIC g266481mmi008.jpg GRAPHIC 60121
11 GRAPHIC g266481mmi009.jpg GRAPHIC 73746
12 GRAPHIC g266481mmi010.jpg GRAPHIC 79737
13 GRAPHIC g266481mmi011.jpg GRAPHIC 67604
  Complete submission text file 0001104659-07-075210.txt   1052806
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 071175315
SIC: 2834 Pharmaceutical Preparations